ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
24.65
+1.22 (5.21%)
Mar 9, 2026, 1:40 PM EDT - Market open
ArriVent BioPharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 24.18 | 15.3 | 9.71 | 6.47 | 3.02 |
| Research & Development | 153.35 | 79 | 64.88 | 30.43 | 8.58 |
| Operating Expenses | 177.53 | 94.31 | 74.59 | 36.91 | 11.59 |
| Operating Income | -177.53 | -94.31 | -74.59 | -36.91 | -11.59 |
| Interest & Investment Income | 11.23 | 13.82 | 5.26 | - | - |
| EBT Excluding Unusual Items | -166.31 | -80.49 | -69.33 | -36.91 | -11.59 |
| Pretax Income | -166.31 | -80.49 | -69.33 | -36.91 | -68.81 |
| Net Income | -166.31 | -80.49 | -69.33 | -36.91 | -68.81 |
| Net Income to Common | -166.31 | -80.49 | -69.33 | -36.91 | -68.81 |
| Shares Outstanding (Basic) | 38 | 31 | 2 | 1 | 1 |
| Shares Outstanding (Diluted) | 38 | 31 | 2 | 1 | 1 |
| Shares Change (YoY) | 22.22% | 1369.88% | 67.64% | 79.57% | - |
| EPS (Basic) | -4.32 | -2.56 | -32.38 | -28.90 | -96.75 |
| EPS (Diluted) | -4.32 | -2.56 | -32.38 | -28.90 | -96.75 |
| EBIT | -177.53 | -94.31 | -74.59 | -36.91 | -11.59 |
Source: S&P Capital IQ. Standard template.
Financial Sources.